Muscarinic thioligands with cyclopentane nucleus

Bioorganic and Medicinal Chemistry

Volumn 4, Issue 12, 1996, Pages 2193-2199

  Piergentili, Alessandro ^a   Pigini, Maria ^a   Quaglia, Wilma ^a   Tayebati, Seyed K ^a   Amenta, Francesco ^a   Sabbatini, Maurizio ^a   Giannella, Mario ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Deoxymuscarine thioderivatives; M2 M3 selectivity; Muscarinic binding affinity; Muscarinic thioligands

Indexed keywords

CYCLOPENTANE DERIVATIVE; METHYLSCOPOLAMINE; MUSCARINE DERIVATIVE; MUSCARINIC AGENT; MUSCARINIC RECEPTOR; RECEPTOR SUBTYPE;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; FRONTAL CORTEX; GUINEA PIG; HEART; ILEUM; MALE; NONHUMAN; RAT; SMOOTH MUSCLE CONTRACTION; STRUCTURE ACTIVITY RELATION; SUBMANDIBULAR GLAND;

ANIMALS; BINDING SITES; BINDING, COMPETITIVE; CEREBRAL CORTEX; CYCLOPENTANES; GUINEA PIGS; HEART; ILEUM; LIGANDS; MALE; MUSCARINE; MYOCARDIUM; N-METHYLSCOPOLAMINE; NEOSTRIATUM; PARASYMPATHOLYTICS; QUATERNARY AMMONIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MUSCARINIC; SCOPOLAMINE DERIVATIVES; STRUCTURE-ACTIVITY RELATIONSHIP; SUBMANDIBULAR GLAND;

EID: 0030470349     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(96)00231-3     Document Type: Article

References (22)

1. 1. Mitchard, M. Drug Metab. Drug Interact. 1988, 6, 183.
2. 2. Gmiro, V. E.; Brovtsyna, N. B.; Poznyakova, L. N.; Danilov, A. F.; Slelkovnikov, S. A.; Khromov-Borisov, N. V. Dokl. Akad. Nauk SSSR. 1982, 265, 488.
3. 3. Gualtieri, F.; Angeli, P.; Giannella, M.; Melchiorre, C.; Pigini, M. Recent Advances in Receptor Chemistry; Gualtieri, F., Giannella, M., Melchiorre, C., Eds.; Elsevier/North-Holland Biomedical Press: Amsterdam, 1979; pp 267-279.
4. 4. Sauerberg, P.; Olesen, P. H.; Nielsen, S.; Treppendahl, S.; Sheardown, M. J.; Honoré, T.; Mitch, C. H.; Ward, J. S.; Pike, A. J.; Bymaster, F. P.; Sawyer, B. D.; Shannon, H. E. J. Med. Chem. 1992, 35, 2274.
5. 5. Angeli, P. Il Farmaco 1995, 50, 565.
6. 6. Enz, A.; Boddeke, H.; Sauter, A.; Rudin, M.; Shapiro, G. Life Sci. 1993, 52, 513.
7. 7. Piergentili, A.; Tayebati, S. K.; Giannella, M. Pharm. Pharmacol. Lett. 1992, 1, 131, and references cited therein.
8. 8. Gualtieri, F.; Brasili, L.; Giannella, M.; Pigini, M. Il Farmaco, Ed. Sc. 1982, 37, 618.
9. 9. Brasili, L.; Giannella, M.; Piergentili, A.; Tayebati, S. K. Med. Chem. Res. 1992, 2, 298.
10. 10. Givens, R. S.; Rademacher, D. R.; Kongs, J.; Dickerson, J. Tetrahedron Lett. 1974, 36, 3211.
11. 11. Jones, D. N.; Blenkinsopp, J.; Edmonds, A. C. F.; Helmy, E.; Taylor, R. J. K. J. Chem. Soc., Perkin I 1973, 2602, and references cited therein.
12. 12. Melchiorre, C.; Giannella, M.; Giardinà, D.; Gualtieri, F. Synth. Commun. 1975, 5, 95.
13. 13. Hall, S. E.; Han, W.-C: Harris, D. N.; Hedberg, A.; Ogletree, M. L. J. Med. Chem. 1989, 32, 974.
14. 14. Melchiorre, C.; Gualtieri, F.; Giannella, M.; Pigini, M.; Cingolani, M. L.; Gamba, G.; Pigini, P.; Rossini, L. Il Farmaco, Ed. Sc. 1975, 30, 300.
15. 15. Claudi, F.; Cingolani, G. M.; Giorgioni, G.; Cardellini, M.; Amenta, F.; Polidori, C. Eur. J. Med. Chem. 1995, 30, 415.
16. 16. Caulfield, M. P. Pharm. Ther. 1993, 58, 319.
17. 17. (a) Waelbroeck, M.; Gillard, M.; Robberecht, P.; Christophe, J. Mol. Pharmacol. 1987, 32, 91.
18. (b) Waelbroeck, M.; Tastenoy, M.; Camus, J.; Christophe, J. Mol. Pharmacol. 1990, 38, 267.
19. (c) Waelbroeck, M.; Camus, J.; Tastenoy, M.; Mutscheler, E.; Strohmann, C.; Tacke, R.; Schjelderup, L.; Aasen, A.; Lambrecht, G.; Christophe, J. Eur. J. Pharmacol. 1992, 227, 33.
20. 18. Cheng, Y. C.; Prusoff, W. H. Biochem. Pharmacol. 1973, 22, 3099.
21. 19. Levey, A. I. Life Sci. 1993, 52, 441.
22. 20. Cohen, S. G.; Elkind, J. L.; Chishti, S. B.; Giner, J.-L. P.; Reese, H.; Cohen, J. B. J. Med. Chem. 1984, 27, 1643.